Alicia is the Global Director of Patient Advocacy to Outcomes for GSK, Hematology*.She joined GSK in January 2020, after spending 12 years at the Multiple Myeloma Research Foundation, (MMRF) where she worked closely with patients, caregivers, myeloma doctors, and industry.

Her passion is to empower patients to become active and informed members of their own care team.In her role at GSK, Alicia is responsible for understanding how patients experience their disease, including how they feel, think and behave throughout their MPN journey.She then brings those insights into actions and strategies with the goal of helping patients have better outcomes and treatment experiences.

Alicia is an avid hiker, cyclist and runner, and is thrilled to join the Sole 2 Soul team!“I am so honored to join this amazing team people living with MPNs as well as caregivers, doctors, patient advocates and CURE.While I can’t walk in your shoes, I can walk beside you, support you and learn about MPNs and the journey that you are all on.”

*Note:GSK completed the acquisition of Sierra Oncology on July 1, 2022.